ArticleContemporary oncology (Poznan, Poland)2013

Research on drug resistance mechanism of trastuzumab caused by activation of the PI3K/Akt signaling pathway.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.